Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 110 results for anticoagulation

  1. Using implantable cardiac monitors to detect atrial arrhythmias (fibrillation/flutter) after cryptogenic stroke

    identifying the cause and initiating appropriate secondary prevention (anticoagulation in case of atrial fibrillation or AF) To increase...

  2. Implementing point-of-care D-dimer tests for deep vein thrombosis (DVT)

    states that if a D-dimer test cannot be obtained within 4 hours, interim anticoagulation should be given. If a person has a low...

  3. Zio XT for detecting cardiac arrhythmias (MTG52)

    Evidence-based recommendations on Zio XT for detecting cardiac arrhythmias.

  4. Introducing implantable cardiac monitors to support detection of atrial fibrillation after cryptogenic stroke at Salford Royal NHS Trust

    of Unknown Source (ESUS) Patients considered suitable for long term anticoagulation Modified Rankin Score (mRs) ≤3 See key learning...

  5. Acute coronary syndromes (NG185)

    This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina. The guideline aims to improve survival and quality of life for people who have a heart attack or unstable angina.

  6. For people with iron-deficiency anaemia, how long before surgery should oral iron supplementation be started, and what is the clinical and cost effectiveness of daily oral iron compared with oral iron given on alternate days?

    a recommendation for research on oral iron supplementation . Anticoagulation for people taking a vitamin K antagonist who need bridging...

  7. What is the clinical and cost effectiveness of preoperative optimisation clinics for older people?

    a recommendation for research on oral iron supplementation . Anticoagulation for people taking a vitamin K antagonist who need bridging...

  8. What is the most clinical and cost-effective strategy, as identified by a consensus survey, for the perioperative management of anticoagulation treatment in people taking a vitamin K antagonist with a target international normalised ratio (INR) of more than 3 who need bridging therapy?

    identified by a consensus survey, for the perioperative management of anticoagulation treatment in people taking a vitamin K antagonist...

  9. Proportion of patients admitted to hospital for stroke with a pre-existing diagnosis of atrial fibrillation, who were not on anticoagulation

    with a pre-existing diagnosis of atrial fibrillation, who were not on anticoagulation Subject(s): Atrial fibrillation

  10. Proportion of patients admitted to hospital for stroke with a pre-existing diagnosis of atrial fibrillation, who were on anticoagulation

    stroke with a pre-existing diagnosis of atrial fibrillation, who were on anticoagulation Subject(s): Atrial fibrillation

  11. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (DG41)

    Evidence-based recommendations on implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke

  12. Perioperative care in adults (NG180)

    This guideline covers care for adults (aged 18 and over) having elective or emergency surgery, including dental surgery. It covers all phases of perioperative care, from the time people are booked for surgery until they are discharged afterward. The guideline includes recommendations on preparing for surgery, keeping people safe during surgery and pain relief during recovery.

  13. Dual Antiplatelet Therapy Post MI - An audit of post-acute coronary syndrome - ticagrelor prescription at Leigh Family Practice

    indefinitely unless they are aspirin intolerant or have an indication for anticoagulation. A second antiplatelet, such as ticagrelor, is...

  14. Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)

    NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19 .

  15. Screening secondary care patients for atrial fibrillation: The SOS-AF service

    CHA2DS2-VASc assessment tool and consider the risks and benefits of anticoagulation. Where appropriate, treatment is started before...